$2.51 (-23.01%)

Volume: 1.855M

Closed: Feb 03, 2023

Hollow Logo Score: -6.359
Cellectis S.A. Stock
$2.51 (-23.01%)

Volume: 1.855M

Closed: Feb 03, 2023

Score Hollow Logo -6.359
NASDAQ:CLLS

Cellectis S.A. Stock Price (Quote)

$2.51 ( -23.01% ) Friday, 3rd Feb 2023

Range Low Price High Price Comment
30 days $2.25 $4.04 Friday, 3rd Feb 2023 CLLS stock ended at $2.51. This is 23.01% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 12.89% from a day low at $2.25 to a day high of $2.54.
90 days $1.83 $4.04
52 weeks $1.83 $6.04

Historical Cellectis S.A. prices

Date Open High Low Close Volume
2023-02-03 $2.26 $2.54 $2.25 $2.51 1 855 071
2023-02-02 $3.26 $3.30 $3.07 $3.26 44 761
2023-02-01 $2.96 $3.15 $2.96 $3.10 17 943
2023-01-31 $2.96 $3.13 $2.90 $3.05 72 142
2023-01-30 $3.09 $3.09 $2.92 $3.01 20 347
2023-01-27 $3.08 $3.14 $3.03 $3.10 97 357
2023-01-26 $3.17 $3.20 $3.06 $3.14 22 247
2023-01-25 $3.19 $3.39 $3.02 $3.23 69 859
2023-01-24 $3.27 $3.36 $3.25 $3.34 52 213
2023-01-23 $3.39 $3.44 $3.30 $3.38 133 187
2023-01-20 $3.05 $3.26 $3.01 $3.06 69 800
2023-01-19 $3.28 $3.31 $2.97 $3.05 124 605
2023-01-18 $3.49 $3.54 $3.31 $3.33 96 837
2023-01-17 $4.00 $4.04 $3.19 $3.38 340 442
2023-01-13 $3.89 $3.89 $3.74 $3.84 68 300
2023-01-12 $3.75 $3.89 $3.61 $3.72 161 202
2023-01-11 $3.62 $3.95 $3.31 $3.56 251 215
2023-01-10 $3.76 $4.01 $3.26 $3.53 517 400
2023-01-09 $3.16 $3.41 $3.04 $3.36 266 337
2023-01-06 $2.59 $2.97 $2.59 $2.83 194 141
2023-01-05 $2.40 $2.60 $2.36 $2.56 127 383
2023-01-04 $2.29 $2.41 $2.29 $2.38 87 893
2023-01-03 $2.27 $2.33 $2.22 $2.27 108 352
2022-12-30 $1.90 $2.11 $1.85 $2.10 166 654
2022-12-29 $1.94 $2.08 $1.85 $1.95 237 058
2022-12-28 $1.85 $1.93 $1.83 $1.85 125 099
2022-12-27 $1.98 $2.04 $1.83 $1.88 115 887
2022-12-23 $2.13 $2.13 $1.89 $1.99 57 015
2022-12-22 $2.00 $2.06 $1.93 $1.97 119 643
2022-12-21 $1.89 $2.05 $1.89 $2.02 123 125
2022-12-20 $1.91 $2.00 $1.91 $1.96 42 985
2022-12-19 $2.01 $2.05 $1.85 $1.90 94 134
2022-12-16 $2.12 $2.25 $2.02 $2.03 718 772
2022-12-15 $2.15 $2.25 $2.15 $2.25 58 428
2022-12-14 $2.16 $2.24 $2.13 $2.20 156 839
2022-12-13 $2.36 $2.50 $2.29 $2.34 156 282
2022-12-12 $2.24 $2.35 $2.23 $2.23 94 228
2022-12-09 $2.25 $2.25 $2.21 $2.21 33 426
2022-12-08 $2.16 $2.27 $2.16 $2.24 44 459
2022-12-07 $2.20 $2.21 $2.13 $2.15 79 334
2022-12-06 $2.25 $2.29 $2.21 $2.21 28 550
2022-12-05 $2.19 $2.27 $2.18 $2.23 91 567
2022-12-02 $2.16 $2.22 $2.15 $2.18 78 329
2022-12-01 $2.24 $2.24 $2.15 $2.18 94 861
2022-11-30 $2.22 $2.25 $2.15 $2.20 73 432
2022-11-29 $2.22 $2.26 $2.17 $2.17 101 268
2022-11-28 $2.41 $2.43 $2.22 $2.22 86 737
2022-11-25 $2.42 $2.42 $2.33 $2.35 47 497
2022-11-23 $2.28 $2.51 $2.28 $2.50 155 024
2022-11-22 $2.10 $2.19 $2.09 $2.17 46 235

Hot Stocks To Watch:

About Cellectis S.A.

Cellectis SA Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT